BackKuros Biosciences AG Overview

Kuros Biosciences AG Total Liabilities

Track Kuros Biosciences AG's total liabilities ($48M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$48.15M
↑ 44.51% YoYΔ $14.83M vs prior year quarter

Peer trimmed avg / median

Loading

Kuros Biosciences AG Total Liabilities History

Loading

Kuros Biosciences AG vs. peers: Total Liabilities Comparison

Loading

Kuros Biosciences AG Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kuros Biosciences AG (CSBTF) FAQ

Kuros Biosciences AG posts a total liabilities of $48M as of June 2026. That compares with $33M in the prior-year period — up 44.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Kuros Biosciences AG's total liabilities was $33M. The latest reading is $48M — a 44.5% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Kuros Biosciences AG's financial statement story. At $48M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CSBTF's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Kuros Biosciences AG's other metric pages and overview cover the third.